EME innovates new generation of biomolecules and modality by utilizing competitive advantage. Also, we have been tackling researches for “unmet medical needs” with our innovative idea. We have been addressing for the drug discovery shown below:
- Multivalent VHHs （multi-specific VHHs, multi-paratopic VHHs, and etc)
- Allosteric function
- Agonist function
- Targeting VHHs for
- ADC(Antibody Drug Conjugate)
- Photoimmunotherapy
- Imaging tests
- Intrabody
- VHHs which has enzymatic activity
- VHHs for cellular therapy and gene therapy
Pipelines
Targets of our drug discovery
- Unmet medical needs
- Undruggable targets
In vitro translation system
is an ‘open’ system
Reconstruction of active-formed membrane proteins with cell-free protein translation systems